Oxaliplatin Agmed

Oxaliplatin, the active ingredient in Oxaliplatin Agmed, is a platinum‑based chemotherapy presented as a sterile solution for intravenous infusion use. It is employed in the treatment of colorectal cancer and related solid tumours, typically administered by oncologists in hospital settings.

GNH USA supplies Oxaliplatin Agmed as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

Oxaliplatin Agmed is a platinum‑based agent that interferes with DNA replication across several oncologic pathways. It is used in the following recognised indications: - Colorectal cancer: Enhances the efficacy of combination chemotherapy regimens such as FOLFOX to reduce tumour growth. - Gastric cancer: Used in combination with other platinum‑based drugs to improve response rates. - Pan‑   y -   t  t ",

The ...